DUBLIN, Ireland, March 8, 2013 /PRNewswire/ -- Research and Markets has announced the addition of the "Injectable Drug Delivery to 2018 Drugs, Devices, Targets, Therapeutics and Forecasts" market research report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape. Highlights - Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injectable drug products by therapeutic indication - Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and … Continue reading →

MORGANTOWN, W.Va. (AP) -- West Virginia University has launched a research center to conduct human clinical trials on new drugs that are being developed, and its first partner is the generic drug maker Mylan Inc. The Clinical and Pharmacological Research Center will recruit volunteers from Morgantown and beyond to participate in the trials, which could lead to partnerships with other companies in the pharmaceutical and biotechnology industries, said WVU Health Sciences Chancellor Christopher Colenda. "This is an important investment for the economic future of our community," he said. The venture was created by the WVU Research Corp. and the WVU Health Sciences Center. It already has a contract with Pennsylvania-based Mylan, which has a manufacturing facility in Morgantown. Mylan officials didn't immediately comment Friday on what kind of drugs the center would test first or when those trials would begin. Dr. Dorian Williams, the center's interim director, said the health and safety of volunteers is the top priority, and all will be fully informed of the risks they face. Participants are paid, but Williams said those payments are strictly regulated and related to the amount of time and blood draws required. "Short, two-weekend studies would typically pay around $200-500," he … Continue reading →

The increasing threat posed by synthetic drugs readily available online or in stores as "legal highs" and the rise of social drug users are causing serious concern among those at the pointy end of Queensland's drug battle. The evidence of the social drug culture is on display every Saturday night in pubs and clubs across the state. The fall-out is acutely felt by emergency workers from hospital casualty departments to frontline police. Experts are concerned about the rise of the social drug user. Over the past month, Fairfax Media has explored the issues around the production and distribution of drugs in Queensland, the effects on users, and the impacts on those desperately working to stem the tide and tackle the toll. Advertisement In this special series Wasted Lives: Queensland's Drug Battle, police, emergency physicians, the state's corruption watchdog, and those most affected by illicit substances describe the drug scene as they see it today. About one in six Queenslanders had used illicit drugs in the 12 months leading up to the 2010 National Drug Survey involving almost 27,000 Australians. The Queensland figure outstripped the national average of 14.7 per cent and was the third highest behind the Northern Territory with … Continue reading →

NEW YORK, March 8, 2013 /PRNewswire/ -- Drugs.com, the leading online clinical drug resource, today announced they have launched the Drugs.com Medication Guide, a mobile app to facilitate patient engagement in their own medication management. The "Drugs.com Medication Guide" app is now available as a free download on the popular iOS and Android mobile platforms. Utilizing the Drugs.com Medication Guide app, patients and caregivers can have instant access to their most recent personal medication records, saved drug interactions lists, and breaking FDA and health news tailored to their needs. In addition, consumers can easily navigate through the most trusted and unbiased sources of medical information to make educated health decisions. "As the U.S. healthcare system moves through the upcoming stages of meaningful use, patients will be empowered to utilize mobile health apps to manage their medications and maintain wellness," said Philip Thornton, CEO of Drugs.com. "The latest Drugs.com Medication Guide app is a practical tool to shorten this learning curve for both patients and caregivers alike. Medication management, safety and adherence will simply become easier." The Drugs.com app provides consumers with easy access to vital health information tools such as MedNotes, the Symptom Checker, and the Complete Drugs A to … Continue reading →